arrow_back Trending Legislation
Share share

Study on COVID-19's Neurological Impact on Individuals with Neurological Diseases

This bill mandates a study on how COVID-19 affects individuals with pre-existing neurological conditions. The findings will be reported to Congress, potentially leading to better understanding and treatment of neurological complications from COVID-19, benefiting public health.
Key points
Directs a study on the neurological impacts of COVID-19 on individuals with neurological diseases.
Requires a report on the study results to be submitted to Congress within 120 days of enactment.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
To direct the Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, to conduct a study on the neurological impacts of COVID-19 on individuals with a neurological disease.
Print number: HR 6813
Sponsor: Rep. Keating, William R. [D-MA-9]
Process start date: 2022-02-22
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch
Summary & Status

Key Questions about Study on COVID-19's Neurological Impact on Individuals with Neurological Diseases

A structured overview of the legislative process, official sources, status and civic context.

What is the official ID of this bill?

The official print number for this legislation is HR 6813.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-02-22.

What are the main provisions?

Key points include:

  • Directs a study on the neurological impacts of COVID-19 on individuals with neurological diseases.
  • Requires a report on the study results to be submitted to Congress within 120 days of enactment.

What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Keating, William R. [D-MA-9].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-28.

Analysis and Potential Impact of HR 6813

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge. Review our public AI processing logs for full transparency, and use Lustra to track active legislation for instant status push notifications.

CATEGORIES

Health